Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candida endocarditis treated with 5-fluorocytosine.

C O Record, J M Skinner, P Sleight

    British Medical Journal
    |January 30, 1971
    PubMed
    Summary

    5-fluorocytosine treatment for Candida endocarditis showed limited success. While one patient with aortic sclerosis survived, two with prosthetic valve endocarditis died, experiencing treatment failure and adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.

    QJM : monthly journal of the Association of Physicians·2008
    Same author

    A framework convention on alcohol control.

    Lancet (London, England)·2007
    Same author

    Hepatitis C virus genotypes in a cohort of Middle Eastern patients.

    Annals of Saudi medicine·2007
    Same author

    Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

    Alimentary pharmacology & therapeutics·2004
    Same author

    Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.

    Journal of clinical pathology·2001
    Same author

    Application of quantitative techniques for the assessment of gastric atrophy.

    Journal of clinical pathology·2001

    Area of Science:

    • Infectious Diseases
    • Cardiology
    • Pharmacology

    Background:

    • Endocarditis, an infection of the heart lining, can be caused by fungal pathogens like Candida species.
    • Treatment of fungal endocarditis, particularly in complex cases, remains a clinical challenge.
    • 5-fluorocytosine is an antifungal agent sometimes used in managing serious Candida infections.

    Observation:

    • This study reports on three patients diagnosed with endocarditis attributed to Candida species.
    • All three patients were treated with the antifungal medication 5-fluorocytosine.
    • Patient characteristics varied, including underlying conditions such as senile aortic sclerosis and prosthetic valve presence.

    Findings:

    • One patient with endocarditis superimposed on senile aortic sclerosis successfully survived the infection following 5-fluorocytosine treatment.
    • Two patients with Candida endocarditis on prosthetic valves did not survive.
    • In the non-surviving patients, 5-fluorocytosine chemotherapy failed to eradicate the fungal infection and was linked to significant adverse events, including bone marrow depression and potential hepatic necrosis.

    Implications:

    • The findings suggest that 5-fluorocytosine may have limited efficacy in treating severe Candida endocarditis, especially in patients with prosthetic valves.
    • Adverse effects associated with 5-fluorocytosine, such as marrow depression and hepatic toxicity, warrant careful monitoring during treatment.
    • Further research is needed to establish optimal antifungal strategies for Candida endocarditis, particularly in high-risk patient populations.

    Related Experiment Videos